Amgen Inc. Common Stock, Including Additional Paid in Capital (Deprecated 2013-01-31)
Amgen Inc. (AMGN) had Common Stock, Including Additional Paid in Capital (Deprecated 2013-01-31) of $29.46 billion as of 2013-03-31, per its 10-Q filed 2013-05-03.
Discontinued › Notes › Equity
us-gaap:CommonStockIncludingAdditionalPaidInCapital · last filed 2013-05-03
- 2013-03-31: Common Stock, Including Additional Paid in Capital (Deprecated 2013-01-31) $29.46B.
- 2012-12-31: Common Stock, Including Additional Paid in Capital (Deprecated 2013-01-31) $29.34B.
- 2012-09-30: Common Stock, Including Additional Paid in Capital (Deprecated 2013-01-31) $29.10B.
- 2012-06-30: Common Stock, Including Additional Paid in Capital (Deprecated 2013-01-31) $28.47B.
| Period end | Common Stock, Including Additional Paid in Capital (Deprecated 2013-01-31) |
|---|---|
| 2013-03-31 | $29.46B 10-Q · filed 2013-05-03 |
| 2012-12-31 | $29.34B 10-Q · filed 2013-05-03 |
| 2012-09-30 | $29.10B 10-Q · filed 2012-11-06 |
| 2012-06-30 | $28.47B 10-Q · filed 2012-08-08 |
| 2012-03-31 | $28.21B 10-Q · filed 2012-05-08 |
| 2011-12-31 | $27.78B 10-K · filed 2013-02-27 |
| 2011-09-30 | $27.60B 10-Q · filed 2011-11-04 |
| 2011-06-30 | $27.51B 10-Q · filed 2011-08-08 |
| 2011-03-31 | $27.38B 10-Q · filed 2011-05-10 |
| 2010-12-31 | $27.30B 10-K · filed 2012-02-29 |
| 2010-09-30 | $27.21B 10-Q · filed 2010-11-08 |
| 2010-06-30 | $27.12B 10-Q · filed 2010-08-09 |
| 2010-03-31 | $27.03B 10-Q · filed 2010-05-07 |
| 2009-12-31 | $26.94B 10-K · filed 2011-02-25 |
| 2009-09-30 | $26.85B 10-Q · filed 2009-11-06 |
| 2009-06-30 | $26.72B 10-Q · filed 2009-08-10 |
| 2008-12-31 | $26.44B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |